Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Quest Diagnostics (NYSE: DGX) | Delayed: 237.93 -1 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.93 | 52 Week High | $86.85 | |||
| Open | $226.50 | 52 Week Low | $59.66 | |||
| Day High | $246.00 | P/E | 44.81 | |||
| Day Low | $226.22 | EPS | $5.31 | |||
| Volume | 867,432 | |||||
